You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Drugs in ATC Class D02BA


✉ Email this page to a colleague

« Back to Dashboard


Drugs in ATC Class: D02BA - Protectives against UV-radiation for topical use

Market Dynamics and Patent Landscape for ATC Class D02BA — Protectives Against UV Radiation for Topical Use

Last updated: January 3, 2026

Summary

This comprehensive analysis explores the current market landscape and patent environment surrounding ATC classification D02BA, focusing on topical protectives against ultraviolet (UV) radiation. As skin cancer rates escalate globally and consumer awareness about UV protection surges, the demand for innovative dermatological formulations intensifies. The analysis delves into market drivers, challenges, key players, patent trends, and research directions, providing actionable insights for stakeholders in pharmaceutical, cosmetic, and biotech sectors.


What Is the Scope of ATC Class D02BA?

The Anatomical Therapeutic Chemical (ATC) classification system assigns D02BA to "Protectives against UV radiation for topical use"—principally including sunscreens and UV-protective skin formulations. This class covers a broad spectrum of products aimed at safeguarding skin from external UV exposure, incorporating both chemical and physical (mineral) filters.

Key Components Covered in D02BA

Subcategories Description Examples
D02BA01 Benzophenones and derivatives Oxybenzone, Dioxybenzone
D02BA02 Salicylates Homosalate, Trolamine salicylate
D02BA03 Cinnamates Octocrylene, Ethylhexyl methoxycinnamate
D02BA04 Particulate filters (minerals) Zinc oxide, Titanium dioxide
D02BA05 Other chemical filters Ensulizole, Octisalate

Market Dynamics for UV-Protection Topicals

1. Global Market Size and Growth Projections

The UV protection market is projected to expand at a compound annual growth rate (CAGR) of 5.8% from 2023 to 2030, driven chiefly by rising skin cancer incidences, increased sun awareness, and technological advances in formulation.

Parameter 2022 2023 Projection (2030)
Market Size ~$11.5 billion ~$12.2 billion ~$20 billion

(Source: Grand View Research, 2023[1])

2. Key Market Drivers

Drivers Impact
Increasing skin cancer rates Amplifies demand for effective UV-protective products
Rising consumer awareness of sun protection Boosts sales of sunscreens and topical UV filters
Product innovation and SPF regulations Enhances efficacy, safety, and market appeal of new formulations
Expansion into emerging markets Growing middle class and outdoor recreation activities expand market reach

3. Challenges and Barriers

Barrier Effect
Regulatory complexities Stringent regulations worldwide constrain product development
Ingredient sensitivities Allergic reactions to chemical filters limit formulations
Environmental concerns Issues over chemical filters’ impact on coral reefs and ecosystems
Market saturation Compressed margins; necessity for differentiation

4. Regional Market Trends

Region Growth Rate (2023-2030) Notable Factors
North America ~6% High incidence of skin cancer; consumer preference for mineral filters
Europe ~5% Strict regulations; eco-friendly formulations gain traction
Asia-Pacific ~7% Rapid urbanization; emerging middle class with sun protection awareness
Latin America ~4.5% Increasing outdoor activities and skin care imports

Patent Landscape in D02BA

1. Patent Filing Trends

Between 2010 and 2022, patent filings related to D02BA increased substantially, reflecting heightened R&D activity. Notable trends include:

  • Rise in formulations combining physical and chemical filters (hybrid formulations)
  • Innovations in nano-materials (e.g., nano-zinc oxide), leading to enhanced transparency and stability
  • Development of eco-friendly and reef-safe filters
  • Targeted delivery systems (e.g., encapsulation) for improved UV filter efficacy
Year Number of Patents Filed Notable Patent Assignees Key Innovations
2010 150 L'Oréal, BASF, Evonik Nano-encapsulation, broad-spectrum filters
2015 300 Croda, Merck, Givaudan Sustainable ingredients, enhanced skin feel
2020 480 BASF, DSM, patent pools (public domain) Reef-safe formulations, combination filters
2022 600+ Multiple biotech startups, Big Pharma Novel physical filters, microencapsulation methods

2. Major Patent Holders and Collaborations

Entity Number of Patents (2022) Focus Areas Notable Collaborations
L'Oréal 120 Broad-spectrum filters, formulations Collaborations with biotech firms for novel filters
BASF 80 Mineral filters, eco-friendly compounds Partnerships with academia for nano-material research
Givaudan 50 Fragrance-embedded sunscreens Cross-sector innovation in sensory appeal
Emerging Startups 50+ Nano-encapsulation, biodegradable filters Strategic alliances with cosmetic firms

3. Patent Trends by Substance Category

Category 2010 2015 2020 2022 Observations
Physical Filters (Minerals) 30 60 150 200 Increased nano formulations and transparency
Benzophenones 50 90 100 120 Regulatory scrutiny over safety concerns
Cinnamates, Salicylates 40 70 80 100 Focus on reducing skin irritation and photo-stability
Novel Ingredients 20 80 150 180 Emphasis on eco-compatibility and sustainability

Comparison of Chemical vs. Mineral UV Filters

Parameter Chemical Filters Mineral Filters
Spectrum Coverage Broad-spectrum (UVB and UVA) Generally UVA and UVB, some focus on UVA1
Transparency Can leave white cast; recent nano-formulations help Translucent, especially with nano formulations
Safety and Regulatory Profile Concerns over hormonal disruption, allergies Generally regarded as safer; eco-conscious appeal
Environmental Impact Potential harm to marine ecosystems when washed Reef-safe, biodegradable options increasing
Stability and Photosensitivity High, but can degrade under sunlight High stability; less prone to photodegradation

Research Directions and Innovation Opportunities

1. Eco-Friendly and Reef-Safe Filters

Growing environmental awareness fuels R&D for biodegradable and reef-safe formulations. Innovations include plant-derived filters, bio-based nanoparticles, and green synthesis techniques.

2. Advanced Delivery Systems

Encapsulation, micro- and nano-emulsions, and smart delivery systems enhance filter stability, skin adherence, and spreadability.

3. Multi-Functional Formulations

Integration of antioxidants, skin repairs agents, and hydrating agents alongside UV filters improves overall skin protection and user experience.

4. Regulatory and Safety Optimization

Regulatory bodies like FDA (USA), EMA (EU), and APEC (Asia-Pacific) are tightening safety standards. Innovations must prioritize non-sensitizing, non-irritating, and non-hormonal filters, with comprehensive safety profiling.


Implications for Industry Stakeholders

Stakeholder Strategic Recommendations
R&D Departments Focus on Eco-friendly, high-efficiency formulations; leverage nanotechnology
Patent Agents Monitor evolving patent landscape for freedom-to-operate; identify innovation gaps
Regulatory Bodies Develop harmonized standards for chemical safety and environmental impact
Manufacturers Invest in sustainable ingredients and advanced delivery systems to meet consumer demand

Conclusion

The D02BA class of UV protectives for topical use is characterized by robust growth driven by emerging health awareness and technological advancements. Patent activity reflects a shift towards environmental sustainability, nano-based formulations, and combination products. Stakeholders must navigate a complex regulatory landscape while innovating in eco-friendliness and safety. Strategic R&D investments aligned with current patent trends can secure competitive advantages in a burgeoning market.


Key Takeaways

  • The global UV protection market is expected to reach ~$20 billion by 2030, with a CAGR of ~5.8%.
  • Patent filings are increasingly focused on nano-encapsulation, eco-compatibility, and hybrid formulations.
  • Mineral filters like zinc oxide and titanium dioxide are gaining premium status due to safety and environmental considerations.
  • Regulatory environments globally are pushing innovation toward reef-safe, non-toxic ingredients.
  • Multi-functional, environmentally friendly, and highly stable formulations represent lucrative future opportunities.

FAQs

1. What are the most promising ingredients in the current patent landscape for D02BA?
Nano zinc oxide and titanium dioxide dominate as physical filters; innovative hybrid formulations combining chemical and mineral filters are also trending.

2. How are environmental regulations influencing patent filings?
Stringent eco-standards promote patents on biodegradable, reef-safe, and natural-origin filters, reducing reliance on traditional chemical filters associated with environmental harm.

3. Are there safety concerns associated with chemical UV filters?
Yes. Some benzophenones and cinnamates have raised hormonal and allergenic safety concerns, leading to regulatory scrutiny and a push for safer alternatives.

4. What role does nano-technology play in D02BA products?
Nano-encapsulation improves transparency, stability, and efficacy of physical filters, significantly influencing patent filings from 2010 onward.

5. How should companies approach patent strategy in this space?
Monitoring global patent trends, investing in eco-friendly and innovative formulations, and securing broad patent protections are crucial to sustain competitive advantage.


References

[1] Grand View Research, "Sun Protection Market Size, Share & Trends Analysis Report," 2023.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.